Skip to Main Content

Paper Details

Duration of Heart Failure With Preserved Ejection Fraction and Outcomes With Sacubitril/Valsartan: Insights From the PARAGON-HF Trial.
J Card Fail
1
2023
HF, HFpEF, Heart Failure, Sacubitril, Valsartan, cardiovascular, heart failure, participants, patient, patients, sacubitril, valsartan
Author NameAffiliation
Milton PackerBaylor Heart and Vascular Institute, Baylor University Medical Center
Carolyn S P LamNational Heart Centre Singapore and Duke-National University of Singapore
Akshay S DesaiBrigham and Women's Hospital and Harvard Medical School
  • 1 - 3

Datasets